Research Points to Protein Buildup as Key Driver of Age-Related Neurological Disease

Scientists have identified a molecular switch that may help explain why aging makes the brain more vulnerable to diseases such as ALS and Huntington’s. In worms, the protein EPS8 builds up with age and triggers signaling that encourages toxic proteins to clump together, damaging neurons and shortening lifespan. Reducing EPS8 activity prevented these harmful aggregates and preserved nerve function.

💛 A quick favor, if you've got a second.

We're really happy that you chose to read one of our stories and sincerely hope you'll stick around to read more. We took our paywall down — for now — but that won't last forever, and when the gate goes back up, we'd love for you to already be on the inside.

It's free. So please enter your email here and don't forget to like and follow us on all of your favorite Social Media platforms!

Share this story:


✉️ Email


💬 Text

Researchers have pinpointed a molecular mechanism that could explain why advancing age increases susceptibility to devastating neurological conditions including ALS and Huntington’s disease. The discovery centers on EPS8, a protein that accumulates over time and initiates a cascade of cellular signals promoting the formation of harmful protein clumps that damage nerve cells. The findings emerged from studies conducted in laboratory worms and suggest a previously unknown connection between aging and neurodegeneration.

When EPS8 levels rise with age in the organism, it activates signaling pathways that cause toxic proteins to cluster together in ways that impair neuronal function. The resulting protein aggregates progressively damage brain cells, ultimately contributing to shortened lifespan and loss of nerve function. This mechanism appears central to how aging primes the nervous system for disease vulnerability.

Researchers demonstrated that diminishing EPS8 activity blocked the formation of these damaging protein clusters and maintained normal nerve cell operation. The findings could eventually inform therapeutic strategies targeting age-related neurological decline, though further research in mammals will be necessary before potential treatments can be developed for human patients.

Share this story:


✉️ Email


💬 Text